Business

Acinetobacter Infections Treatment Market – Global Outlook and Forecast 2022-2028

Acinetobacter Infections Treatment

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or species of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

This report contains market size and forecasts of Acinetobacter Infections Treatment in Global, including the following market information:

 

  • Global Acinetobacter Infections Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)

The global Acinetobacter Infections Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sulbactam Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acinetobacter Infections Treatment include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics and Achaogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Acinetobacter Infections Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acinetobacter Infections Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acinetobacter Infections Treatment Market Segment Percentages, by Type, 2021 (%)

  • Sulbactam
  • Carbapenems
  • Aminoglycosides
  • Polymyxins
  • Tetracyclines
  • Others

Global Acinetobacter Infections Treatment Market, by Pipeline, 2017-2022, 2023-2028 ($ millions)

Global Acinetobacter Infections Treatment Market Segment Percentages, by Pipeline, 2021 (%)

  • ETX2514
  • Nacubactam RG6080
  • Arenicin
  • VXD-001
  • Small Molecule Antibiotic
  • AR-401 mAB
  • LCB01-0371 (PO)
  • GN-4474
  • Antibacterial Antibody
  • Others

Global Acinetobacter Infections Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acinetobacter Infections Treatment Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Acinetobacter Infections Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Acinetobacter Infections Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Entasis Therapeutics
  • Roche
  • Adenium Biotech
  • Vaxdyn
  • Hsiri Therapeutics
  • Aridis Pharmaceuticals
  • LegoChem Biosciences
  • Atterx Biotherapeutics
  • Achaogen
  • Peptilogics
  • Sealife PHARMA
  • Shionogi
  • Techulon
  • Tetraphase Pharmaceuticals

Table of content

1 Introduction to Research & Analysis Reports
1.1 Acinetobacter Infections Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Pipeline
1.3 Global Acinetobacter Infections Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acinetobacter Infections Treatment Overall Market Size
2.1 Global Acinetobacter Infections Treatment Market Size: 2021 VS 2028
2.2 Global Acinetobacter Infections Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acinetobacter Infections Treatment Players in Global Market
3.2 Top Global Acinetobacter Infections Treatment Companies Ranked by Revenue
3.3 Global Acinetobacter Infections Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acinetobacter Infections Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acinetobacter Infections Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acinetobacter Infections Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acinetobacter Infections Treatment C

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Global Acinetobacter Infections Treatment Market Size, Status and Forecast 2022

Global and China Acinetobacter Infections Treatment Market Size, Status and Forecast 2021-2027

China Acinetobacter Infections Treatment Market Report & Forecast 2021-2027

Global Acinetobacter Infections Treatment Market Insights and Forecast to 2027

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button